Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from American Vanguard ( (AVD) ) is now available.
On May 7, 2025, AMVAC Chemical Corporation, a subsidiary of American Vanguard, amended its loan agreement with a group of commercial lenders led by BMO Bank. The amendment extends the deadlines for delivering financial statements and reduces the borrowing capacity under the revolving credit facility by $60 million, reflecting changes from previous amendments.
Spark’s Take on AVD Stock
According to Spark, TipRanks’ AI Analyst, AVD is a Neutral.
American Vanguard’s stock is currently under pressure due to financial performance challenges, with negative earnings and declining revenues. The technical analysis indicates bearish trends, and the valuation is weak due to poor profitability. However, potential positives include cash flow improvements, strategic leadership changes, and growth in specific business segments, which offer room for optimism if the company successfully navigates its challenges.
To see Spark’s full report on AVD stock, click here.
More about American Vanguard
American Vanguard Corporation, through its principal operating subsidiary AMVAC Chemical Corporation, operates in the chemical industry, focusing on providing agricultural and specialty chemicals.
Average Trading Volume: 200,349
Technical Sentiment Signal: Sell
Current Market Cap: $122.3M
For a thorough assessment of AVD stock, go to TipRanks’ Stock Analysis page.